A Multicenter Study of Hereditary Transthyretin Amyloidosis in China
- 20 February 2025
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 97 (6) , 1158-1167
Abstract
Objective: Hereditary transthyretin amyloidosis (ATTRv) is an autosomal dominant genetic disease characterized by the misfolding and deposition of the transthyretin (TTR) protein. This study aimed to describe the clinical and genetic characteristics of ATTRv in a large multicenter Chinese cohort.Methods: Patients from 14 centers were included in the study. The clinical and genetic characteristics of all patients were summarized. The peripheral blood white blood cell mitochondrial DNA (mtDNA) was detected in offspring from different genders.Results: A total of 202 individuals with ATTRv from 148 families were identified. The average age of onset was 50.6 ± 12.4 years. Among these cases, 117 (57.9%) were classified as late‐onset (≥50 years) and 85 (42.1%) as early‐onset. Overall, the length dependent axonal sensorimotor peripheral neuropathy was the predominant phenotype (89.1%). A total of 42 heterozygous missense variants and 1 deletion variant were identified. The most common variants were Val30Met (19.8%) and Ala97Ser (15.8%) and patients with Val30Met and Ala97Ser were mostly late‐onset in our cohort. Thirty‐nine of these patients died with a mean age of 56.1 ± 13.5 years. Anticipation according to gender groups of offspring‐parent pairs was different, and mother‐son pairs showed the largest anticipation. The copies of mtDNA in the mother's offspring outnumbered those of the father's offspring (p < 0.001).Interpretation: This study highlights that ATTRv patients in China exhibit high heterogeneity in their initial symptoms. The most common variants observed in this cohort is Val30Met. The mtDNA copy number shows gender‐linked effects. These results can impact ATTRv diagnosis and patient care strategies. ANN NEUROL 2025;97:1158–1167Keywords
This publication has 41 references indexed in Scilit:
- Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databankAnnals of Clinical and Translational Neurology, 2023
- Expert consensus on the monitoring of transthyretin amyloid cardiomyopathyEuropean Journal of Heart Failure, 2021
- Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2020
- Transthyretin Cardiac Amyloidosis: An Update on Diagnosis and TreatmentESC Heart Failure, 2019
- Clinical and genetic profiles of hereditary transthyretin amyloidosis in TaiwanAnnals of Clinical and Translational Neurology, 2019
- Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in JapanJournal of Neurology, 2017
- Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac ImagingJAMA Cardiology, 2016
- Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in FranceAnnals of Neurology, 2015
- Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS)American Heart Journal, 2012
- Measurement of Mitochondrial DNA Copy Number2011